| |
| |
|
| Insider
Information: |
Meyer Colin John |
| Relationship: |
Chief Innovation Officer |
| City: |
Irving |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.5
|
| Percentage
Gain/Loss : |
0.0%
|
 447.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Reata Pharmaceuticals Inc |
RETA |
Chief Innovation Officer |
2023-09-26 |
0 |
2016-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RETA |
Reata Pharmaceuticals Inc |
Chief Innovation Officer |
• – – |
2023-09-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(81,633) |
0 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Innovation Officer |
• – – |
2023-08-16 |
4 |
S |
$168.74 |
$100,569 |
D/D |
(596) |
81,633 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Innovation Officer |
• – – |
2023-08-15 |
4 |
S |
$169.07 |
$362,483 |
D/D |
(2,144) |
82,229 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Innovation Officer |
• – – |
2023-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
84,373 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Innovation Officer |
• – – |
2023-05-16 |
4 |
S |
$80.94 |
$50,590 |
D/D |
(625) |
78,373 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Innovation Officer |
• – – |
2023-05-15 |
4 |
S |
$84.76 |
$476,473 |
D/D |
(5,608) |
78,998 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Innovation Officer |
• – – |
2023-03-07 |
4 |
S |
$84.57 |
$52,518 |
D/D |
(621) |
84,606 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Innovation Officer |
• – – |
2023-03-03 |
4 |
S |
$87.35 |
$461,732 |
D/D |
(5,286) |
85,227 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Innovation Officer |
• – – |
2023-03-02 |
4 |
S |
$85.23 |
$7,683,492 |
D/D |
(88,636) |
90,513 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Innovation Officer |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
88,636 |
179,149 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Innovation Officer |
• – – |
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
90,513 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Innovation Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
23,513 |
75,513 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Research Officer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
52,000 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Research Officer |
• – – |
2020-11-17 |
4 |
S |
$164.44 |
$1,057,571 |
D/D |
(6,395) |
72,000 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Research Officer |
• – – |
2020-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,395 |
78,395 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Research Officer |
• – – |
2020-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
18,605 |
90,605 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Research Officer |
• – – |
2020-11-16 |
4 |
S |
$170.48 |
$3,181,577 |
D/D |
(18,605) |
72,000 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Research Officer |
• – – |
2020-11-09 |
4 |
AS |
$175.00 |
$4,375,000 |
D/D |
(25,000) |
72,000 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2019-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
69,828 |
97,000 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2016-08-16 |
4 |
B |
$16.26 |
$113,820 |
D/D |
7,000 |
27,172 |
2.74 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
See Remarks |
• – – |
2016-06-01 |
4 |
B |
$11.00 |
$110,000 |
D/D |
10,000 |
20,172 |
2.74 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
See Remarks |
• – – |
2016-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,172 |
10,172 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
